NM_000546.6:c.523C>G
Variant summary
The NM_000546.6(TP53):c.523C>G (p.Arg175Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant has a gnomAD grpmax filtering allele frequency (95% CI) of 0.00000072, indicating it is observed in the general population. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000545325: Experimental studies have shown that this missense change affects TP53 function (PMID:8062826, 9546439, 12007217, 12826609, 20516128, 21343334, 23263379, 24573247)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175C: Uncertain_significance (ClinVar VariationId 245851, 3 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) A different missense variant at the same amino acid position has been reported as oncogenic in ClinVar. The variant position is a cancer hotspot (cancerhotspots.org): 570 samples carry this exact amino acid change out of 2850 samples with a variant at this residue. This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Publications
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- Li-Fraumeni syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- Li-Fraumeni syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp
- adrenocortical carcinoma, hereditaryInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- bone marrow failure syndrome 5Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- colorectal cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- choroid plexus carcinomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 20 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000545325: Experimental studies have shown that this missense change affects TP53 function (PMID: 8062826, 9546439, 12007217, 12826609, 20516128, 21343334, 23263379, 24573247).; SCV005201132: "In vitro assays performed in yeast and/or human cell lines showed non-functional transactivation and loss of growth suppression activity indicating that this variant impacts protein function (PS3; PMIDs: 12826609, 30224644, 29979965)."; SCV000664381: Multiple functional studies in both yeast and mammalian cells have shown a loss of transactivation activity for this variant (Monti P et al. Mol. Cancer Res., 2011 Mar;9:271-9; Ory K et al. EMBO J., 1994 Aug;13:3496-504; Flaman JM et al. Oncogene, 1998 Mar;16:1369-72; IARC TP53 database: Kato S et al. Proc Natl Acad Sci USA. 2003 Jul 8;100(14):8424-9; Zerdoumi Y et al. Hum. Mol. Genet., 2017 07;26:2591-2602). Studies conducted in human cell lines indicate this alteration is deficient at growth suppression (Kotler E et al. Mol. Cell 2018 Jul;71:178-190.e8; Giacomelli AO et al. Nat. Genet. 2018 Oct;50:1381-1387).; SCV001820208: Published functional studies demonstrate a damaging effect: non-functional transactivation and loss of growth suppression activity (Ory et al., 1994; Flaman et al., 1998; Kato et al., 2003; Zerdoumi et al., 2017; Giacomelli et al., 2081; Kotler et al., 2018); SCV004933069: Functional studies indicate this variant impacts protein function [PMID: 29979965]. | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 38 pathogenic, 5 benign (OR vs. background: 35.0). | ||
| PM2Absent/extremely low in population databases | Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000072 — very rare for AD/XL gene (threshold 0.0001) — PM2 moderate. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R175H: Pathogenic (ClinVar VariationId 12374, 3 stars); Other variants at the same amino acid residue (not pathogenic): p.R175?: Uncertain_significance (ClinVar VariationId 2687679, 0 stars); p.R175C: Uncertain_significance (ClinVar VariationId 245851, 3 stars); p.R175= (synonymous): Benign/Likely_benign (ClinVar VariationId 1527986, 2 stars) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate). | ||
| PP5Reputable source reports pathogenic | ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000546.6. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | MANE Select | c.523C>G p.Arg175Gly | missense | Exon 5 of 11 | Prot: NP_000537.3 | |
TP53 | c.523C>G p.Arg175Gly | missense | Exon 5 of 11 | Prot: NP_001119584.1 | ||
TP53 | c.523C>G p.Arg175Gly | missense | Exon 6 of 12 | Prot: NP_001394191.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TP53 | TSL:1MANE Select | c.523C>G p.Arg175Gly | missense | Exon 5 of 11 | Prot: ENSP00000269305.4 UniProt: | |
TP53 | TSL:1 | c.523C>G p.Arg175Gly | missense | Exon 5 of 11 | Prot: ENSP00000391478.2 UniProt: | |
TP53 | TSL:1 | c.406C>G p.Arg136Gly | missense | Exon 4 of 10 | Prot: ENSP00000478219.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 4 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD4 exome Warning | AF: 0.00000205 | AC:3 | Hom:0 | AN:1461882 | Cov:35 |
GnomAD4 genome | Cov:33 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000192 | AC:1 | Hom:0 | AN:51978 | |
Local & regional cohorts 1 source | |||||
Turkish Variome | AF: 0.000648 | AC:1 | Hom:0 | AN:1544 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 27 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.55 | D |
BayesDel_noAF | Pathogenic | 0.55 | |
CADD | Pathogenic | 27 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.88 | D |
Eigen | Uncertain | 0.45 | |
Eigen_PC | Uncertain | 0.31 | |
FATHMM_MKL | Pathogenic | 0.98 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.8 | |
GPN-Star score | N/A | 9.8 | |
LIST_S2 | Pathogenic | 0.98 | D |
M_CAP | Pathogenic | 0.90 | D |
MetaRNN | Pathogenic | 0.99 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 0/100 | disease causing (ClinVar) |
MutationAssessor | Pathogenic | 3.3 | M |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -4.5 | |
PrimateAI | Uncertain | 0.63 | T |
PromoterAI | N/A | -0.059 | Neutral |
PROVEAN | Pathogenic | -6.8 | D |
REVEL | Pathogenic | 0.83 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.99 | |
VESM-3B | Benign | -12 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- TP53
- Score
- 1.04